Honoring a life scientist’s lifesaving science
Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
Dr. Fajgenbaum and his research on Castleman's disease featured in the Wall Street Journal
The BRCA1 (BReast CAncer gene 1) and BRCA2 are genes that produce proteins crucial for DNA repair. Women with inactivating mutations in BRCA genes face elevated lifetime risks of recurrent breast and ovarian cancers. Dr. Katherine L. Nathanson of the University of Pennsylvania discusses the complexities of BRCA related breast & ovarian cancers, ongoing research and the potential avenues for future breakthroughs.
Dr. Marina Cuchel speaks about Lecithin Cholesterol Acyltransferase (LCAT) deficiency, a genetic disorder that affects the body’s ability to process cholesterol. It is characterized by cloudiness of the clear front surface of the eye (corneal opacities), a shortage of red blood cells (hemolytic anemia), and kidney failure.
AACI Clinical Research Innovation 2023 Abstracts and Posters book is now available featuring seven abstracts, posters from ACC-CRU Clinical Research Professionals
An initiative developed at the ACC-CRU engages CRPs by encouraging them to develop proposals for projects aimed at improving the process of conducting clinical research.
Link: Philadelphia Inquirer - Health (Penn Medicine BioBank) More than 260,000 people have signed up to participate in the project, called Penn Medicine BioBank,agreeing to have their samples stored in secure, negative-80 degree freezers. By cross-referencing participants’ DNA with their electronic health records,researchers have discovered genetic variants related to heart disease, hearing loss, diabetes, glaucoma, and muscular dystrophy, among other conditions.
IACRN held its annual conference in Philadelphia in 2023. 20 Clinical Research Nurses from Penn Medicine attended, and presented 9 sessions at the conference demonstrating their robust expertise in the field, represented Penn Medicine and networked with CRNs from around the world.
Susan Domchek, MD discusses the INO 5401 Vaccination in BRCA1/2 Mutation Carriers Study, which is testing an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations.
The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square
Tune into Good Morning America on Monday, Oct. 2 to hear Kate and her doctors, including oncologist Hayley Knollman and breast surgeon Lola Fayanju, share her incredible story.
Findings indicate the potential for monitoring disease risk through inexpensive, unintrusive continuous measures of skin temperature
Highest Honor Bestowed for Foundational Discoveries that Gave the World a Vaccine to Fight COVID-19 Pandemic
We strive to increase patient care options through new drugs and devices not yet available to the general public. We support investigators as they work to improve and advance medical care, while ensuring that all our research remains safe for patients and other study participants.